Aardex Group – a company focused on remote research and healthcare adherence – and Cambridge Cognition have firmed a partnership up to provide monitoring during hybrid and decentralised clinical trials (DCTs).
The link-up will involve the incorporation of Aardex’s MEMS platform, which specialises in dosing capture and an analytics system, with Cambridge Cognition’s Clinpal DCT platform, which includes a video consultation, electronic informed consent and a research database.
